SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MAGNUM VENTURES

BSE: 532896 28 Jun 2025
Commodities
₹ 25.8
MAGNUM VENTURES LIMITED specializes in Paper & Paper Products within the Commodities sector.

MAGNUM VENTURES - Share Price & Details

Market Cap
₹174.0
High /Low
56.6 / 22.9
Stock P/E
17.1
Book Value
₹105.0
Dividend Yield
0.0
ROCE
3.66
ROE
₹1.48
Face Value
10.0
PEG Ratio
0.91
EVEBITDA
₹4.66
Debt
208
CMP / FCF
25.0
Debt to equity
₹0.3
NP Ann
9.50
High price all time
77.8
Piotroski score
₹4.0
Graham Number
58.0
No. Eq. Shares
6.64
Net CF
₹-30.6
Net profit
9.50
Price to book value
0.25
Interest Coverage
₹1.02
Low price all time
1.53
Industry PE
16.9
Reserves
₹629
Free Cash Flow
₹-38.7

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Southern Gas Ltd.,NANANANA0.050.03
Indo Gulf Industries Ltd.,NANANANA0
MAGNUM VENTURES LTD.NANANANA174.017.1
NAGPUR POWER & INDUSTRIES LTD.NANANANA16559.8
SOUTH INDIA PAPER MILLS LTD.NANANANA165

Peer Comparison Chart


About MAGNUM VENTURES

MAGNUM VENTURES LIMITED, with Security Code 532896, is a leading player in the Paper & Paper Products industry, categorized under the Commodities sector, offering Equity instruments.


Latest News

Why Magnum Ventures' (NSE:MAGNUM) Shaky Earnings Are Just The Beginning Of Its Problems

(05 Jun 2025)
A lackluster earnings announcement from Magnum Ventures Limited ( NSE:MAGNUM ) last week didn't sink the stock price...
Read more →

Magnum Ventures Standalone March 2025 Net Sales at Rs 118.89 crore, down 9.22% Y-o-Y

(29 May 2025)
Net Sales at Rs 118.89 crore in March 2025 down 9.22% from Rs. 130.97 crore in March 2024. Story continues below Advertisement.
Read more →

Magnum Ventures Reports Significant Profit Growth Amid Rising Interest Expenses and Low ROCE

(29 May 2025)
Magnum Ventures has reported notable financial improvements for the quarter ending March 2025, with significant increases in both profit before and after...
Read more →

Magnum Ventures Reports Strong Profit Growth Amid Rising Interest Costs and Liquidity Challenges

(29 May 2025)
Magnum Ventures has announced its financial results for the quarter ending March 2025, highlighting significant growth in Profit Before Tax and Profit After...
Read more →

Q4 results: Aurobindo Pharma, Shilpa Medicare, Nazara Technologies to announce March quarter numbers on May 26; check details

(29 May 2025)
Auropbindo Pharma, Shilpa Medicare, Yathath Hospital, Nazara Technologies, Olectra Greentech, Orchid Pharma, RateGain Travel technologies...
Read more →

Magnum Ventures standalone net profit declines 59.87% in the March 2025 quarter

(27 May 2025)
Sales decline 9.22% to Rs 118.89 crore. Net profit of Magnum Ventures declined 59.87% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 13.43...
Read more →